{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:20:42Z","timestamp":1788279642823,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014862","name":"Yangzhou Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioadv.2026.215110","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:11:44Z","timestamp":1787267504000},"page":"215110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acid-activated Fe-doped layered double hydroxides coupling FAK blockade and chemodynamic therapy for triple-negative breast cancer"],"prefix":"10.1016","volume":"189","author":[{"given":"Xiaokang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qige","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bioadv.2026.215110_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.215110_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): emerging therapeutic opportunities","volume":"628","author":"Sabit","year":"2025","journal-title":"Cancer Lett."},{"issue":"15_suppl","key":"10.1016\/j.bioadv.2026.215110_bb0015","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.e12580","article-title":"A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC","volume":"36","author":"Losurdo","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215110_bb0020","first-page":"716","article-title":"Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer","volume":"4","author":"Sun","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioadv.2026.215110_bb0025","first-page":"443","article-title":"A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth","volume":"50","author":"Caliendo","year":"2025","journal-title":"Bioact. Mater."},{"issue":"8039","key":"10.1016\/j.bioadv.2026.215110_bb0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41586-024-08031-6","article-title":"AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution","volume":"635","author":"Schade","year":"2024","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.bioadv.2026.215110_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202205462","article-title":"Walking dead tumor cells for targeted drug delivery against lung metastasis of triple-negative breast cancer","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.215110_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2023.101070","article-title":"Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer","volume":"134","author":"Kong","year":"2023","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.bioadv.2026.215110_bb0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12943-025-02456-x","article-title":"Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy","volume":"24","author":"Sabeel","year":"2025","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215110_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccell.2019.01.009","article-title":"A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the hippo pathway through FAK","volume":"35","author":"Feng","year":"2019","journal-title":"Cancer Cell"},{"issue":"6574","key":"10.1016\/j.bioadv.2026.215110_bb0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/380538a0","article-title":"A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK","volume":"380","author":"Richardson","year":"1996","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215110_bb0060","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215110_bb0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41392-025-02395-5","article-title":"Focal adhesion kinase\/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215110_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bjc.2016.190","article-title":"Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways","volume":"115","author":"Zhang","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215110_bb0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00204-014-1290-y","article-title":"In vivo toxicity, metabolism and pharmacokinetic properties of FAK inhibitor 14 or Y15 (1,2,4,5-benzenetetramine tetrahydrochloride)","volume":"89","author":"Golubovskaya","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"38","key":"10.1016\/j.bioadv.2026.215110_bb0080","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1021\/acsanm.5c03343","article-title":"Methotrexate-conjugated therapeutic carbon dots with intrinsic anticancer activity for breast cancer cell inhibition","volume":"8","author":"Chen","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215110_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-12-0701","article-title":"Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide","volume":"12","author":"Golubovskaya","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215110_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","article-title":"Cancer nanomedicine","volume":"22","author":"Bhatia","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215110_bb0095","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215110_bb0100","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215110_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202502817","article-title":"Electromagnetic wireless remote control of reprogramming immune dysfunction via N-doped carbon dots-mesoporous silica-mediated cuproptosis and dendritic cell retention","volume":"15","author":"Lien","year":"2026","journal-title":"Adv. Healthc. Mater."},{"issue":"25","key":"10.1016\/j.bioadv.2026.215110_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202519998","article-title":"Zr-based metal-organic framework dual-sensitized by carbon dot sonosensitizers and MnO2-x nanozymes for cGAS-STING activation enhanced sonocatalytic-immunotherapy","volume":"36","author":"Xiao","year":"2026","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215110_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-023-01460-2","article-title":"Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.bioadv.2026.215110_bb0120","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1039\/D2CS00236A","article-title":"Layered double hydroxide-based nanomaterials for biomedical applications","volume":"51","author":"Hu","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215110_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309562","article-title":"Ultrathin clay nanoparticles-mediated mutual reinforcement of ferroptosis and cancer immunotherapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.bioadv.2026.215110_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407914","article-title":"Sulfate radical based in situ vaccine boosts systemic antitumor immunity via concurrent activation of necroptosis and STING pathway","volume":"36","author":"Huang","year":"2024","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215110_bb0135","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1021\/acsnano.2c02183","article-title":"Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking tumor cell autophagy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.bioadv.2026.215110_bb0140","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1021\/jacs.2c00749","article-title":"Acid neutralization and immune regulation by calcium-aluminum-layered double hydroxide for osteoporosis reversion","volume":"144","author":"Fu","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2026.215110_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109746","article-title":"Layered double hydroxide nanoplatform synergizes with sonodynamic therapy to induce dual activation of cuproptosis and ferroptosis for breast cancer treatment","volume":"174","author":"Zhu","year":"2026","journal-title":"Bioorg. Chem."},{"issue":"27","key":"10.1016\/j.bioadv.2026.215110_bb0150","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","article-title":"Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation","volume":"19","author":"Huynh","year":"2025","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215110_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210238","article-title":"Strategies for enhancing cancer chemodynamic therapy performance","volume":"2","author":"Jana","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.bioadv.2026.215110_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2024.12.072","article-title":"Ascorbate-loaded Mg-Fe layered double hydroxide for osteomyelitis treatment","volume":"378","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215110_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003458","article-title":"Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.215110_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.123987","article-title":"Atomic-valence engineering of a Mn(III)-tuned sonozyme system for multimodal tumor immunotherapy","volume":"329","author":"Hu","year":"2026","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215110_bb0175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215110_bb0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826004103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826004103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:43:20Z","timestamp":1788277400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826004103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S2772950826004103"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215110","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid-activated Fe-doped layered double hydroxides coupling FAK blockade and chemodynamic therapy for triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215110"}}